Related Experiment Video
Updated: Oct 3, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines
Syed Mohammed Basheeruddin Asdaq1, Shahamah Jomah2, Syed Imam Rabbani3
1Department of Pharmacy Practice, College of Pharmacy, AlMaarefa University, Dariyah, Riyadh 13713, Saudi Arabia.
Abstract:
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has thrown a challenge to the scientific community. Several interventions to stop or limit the spread of infection have failed, and every time the virus emerges, it becomes more contagious and more deadly. Vaccinating a significant proportion of the population is one of the established methods to achieve herd immunity. More than 100 COVID-19 vaccines have been designed and tested against the virus. The development of a new vaccine takes years of testing, but due to the pandemic, healthcare authorities have given emergency use authorization for a few vaccines. Among them are BioNTech and Moderna vaccines (mRNA based); ChAdOx1, Gam-COVID-Vac, Janssen vaccines (vector-based); CoronaVac, COVAXIN (virus inactivated); and EpiVacCorona vaccine (viral peptide). Mixtures of vaccines are also being tested to evaluate their efficacy against mutant strains of SARS-CoV-2. All these vaccines in clinical trials have shown robust production of neutralizing antibodies sufficient to prevent infection. Some of the vaccinated people reported serious complications. However, no definitive relationship could be established between vaccination administration and the occurrence of these complications. None of the COVID-19 vaccines approved to date have been found to be effective against all of the SARS-CoV-2 variants.
Insights
COVID-19 vaccines, including mRNA and vector-based types, were rapidly developed. While effective at producing antibodies, their efficacy against all SARS-CoV-2 variants remains uncertain, and serious complications lack definitive links to vaccination.
Area of Science:
- Immunology
- Virology
- Public Health
Background:
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) presents a significant global health challenge.
- Previous interventions have been insufficient to control the spread and severity of the virus.
- Vaccination is a key strategy for achieving herd immunity against infectious diseases.
Purpose of the Study:
- To review the development and efficacy of various COVID-19 vaccines.
- To assess the antibody response and potential complications associated with COVID-19 vaccination.
- To evaluate the effectiveness of current vaccines against emerging SARS-CoV-2 variants.
Main Methods:
- Review of over 100 designed and tested COVID-19 vaccines.
- Analysis of emergency use authorizations granted for vaccines.
- Examination of clinical trial data on antibody production and reported complications.
- Assessment of vaccine efficacy against SARS-CoV-2 variants.
Main Results:
- Multiple vaccine platforms (mRNA, vector-based, inactivated virus, viral peptide) have been developed.
- Clinical trials demonstrate robust neutralizing antibody production for most vaccines.
- Some serious complications were reported post-vaccination, but causality remains undetermined.
- No current vaccine is effective against all SARS-CoV-2 variants.
Conclusions:
- Rapid development of COVID-19 vaccines has provided a critical tool against the pandemic.
- While vaccines induce protective antibodies, ongoing monitoring for efficacy against variants and rare complications is necessary.
- Further research is needed to ensure comprehensive protection against evolving SARS-CoV-2 strains.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Preclinical Development: Overview
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

